# Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

> **NCT00245713** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 40 (—)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** levetiracetam

## Key facts

- **NCT ID:** NCT00245713
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-11
- **Final completion:** 2004-11
- **Target enrollment:** 40 (—)
- **Last updated:** 2013-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245713, "Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00245713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*